Table 3.
Global data of seroprevalence of HBV & HCV in HD centres
| Virus | Place | Author | Year | Prevalence |
|---|---|---|---|---|
| HBV | Western Europe Japan &USA | Burdick et al [6] | 2003 | 0-6.6% |
| Middle East: Saudi Arabia & Bahrain | Almawi WY et al [7] | 2004 | 11.8% & 3.7% | |
| Turkey | Yakaryilmaz et al [8] | 2006 | 13.3% | |
| Brazil | Ferreira et al [9] | 2006 | 2.4-10% | |
| Asia & Pacific countries | Johnson et al [10] | 2009 | 1.3% & 14.6% | |
| North Indian data | Malhotra R et al [11] | 2016 | 1.5-33.5% | |
| HCV | United Kingdom | Wreghitt et al. [12]. | 1999 | 4% |
| Saudi Arabia | Souqiyyeh et al [13] | 2001 | 50% | |
| Germany | Hinrichsen H et al [14] | 2002 | 6% | |
| Slovenia | Buturovic-Ponikvar et al [15] | 2003 | 1.9% | |
| Casablanca | Boulaajaj K et al [16] | 2005 | 76% | |
| Egypt | ZahranAM [17] | 2014 | 49.6% | |